Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

PACS Group, Inc. (PACS)PACS

Upturn stock ratingUpturn stock rating
PACS Group, Inc.
$40.8
Delayed price
Profit since last BUY22.97%
Consider higher Upturn Star rating
upturn advisory
BUY since 45 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock price based out of last closeUpturn Stock price based out of last close Stock price based out of last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

09/18/2024: PACS (2-star) has a low Upturn Star Rating. Not recommended to BUY.

Analysis of Past Upturns

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: Consider higher Upturn Star rating
Profit: 22.97%
Upturn Advisory Performance Upturn Advisory Performance5
Avg. Invested days: 45
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 3
Last Close 09/18/2024
Type: Stock
Today’s Advisory: Consider higher Upturn Star rating
Profit: 22.97%
Avg. Invested days: 45
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 3
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/18/2024
Upturn Advisory Performance Upturn Advisory Performance5

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 6.32B USD
Price to earnings Ratio 66.75
1Y Target Price 41
Dividends yield (FY) -
Basic EPS (TTM) 0.61
Volume (30-day avg) 803458
Beta -
52 Weeks Range 22.61 - 42.25
Updated Date 09/15/2024
Company Size Mid-Cap Stock
Market Capitalization 6.32B USD
Price to earnings Ratio 66.75
1Y Target Price 41
Dividends yield (FY) -
Basic EPS (TTM) 0.61
Volume (30-day avg) 803458
Beta -
52 Weeks Range 22.61 - 42.25
Updated Date 09/15/2024

Earnings Date

Report Date -
When -
Estimate -
Actual -
Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 2.59%
Operating Margin (TTM) 0.07%

Management Effectiveness

Return on Assets (TTM) -
Return on Equity (TTM) -

Valuation

Trailing PE 66.75
Forward PE 21.37
Enterprise Value 8918169247
Price to Sales(TTM) 1.78
Enterprise Value to Revenue 2.51
Enterprise Value to EBITDA 41.25
Shares Outstanding 155178000
Shares Floating 43906363
Percent Insiders 82.76
Percent Institutions 21.54
Trailing PE 66.75
Forward PE 21.37
Enterprise Value 8918169247
Price to Sales(TTM) 1.78
Enterprise Value to Revenue 2.51
Enterprise Value to EBITDA 41.25
Shares Outstanding 155178000
Shares Floating 43906363
Percent Insiders 82.76
Percent Institutions 21.54

Analyst Ratings

Rating 4.83
Target Price -
Buy 1
Strong Buy 5
Hold -
Sell -
Strong Sell -
Rating 4.83
Target Price -
Buy 1
Strong Buy 5
Hold -
Sell -
Strong Sell -

AI Summarization

PACS Group, Inc. Comprehensive Overview

Disclaimer: This information is intended for educational purposes only and should not be interpreted as financial advice. It is important to consult with a qualified financial advisor before making any investment decisions.

Company Profile

History and Background: PACS Group, Inc. (NASDAQ: PACS) was founded in 1994 and has since been focusing on providing cloud-based healthcare and information technology (IT) solutions to the ambulatory surgery and endoscopy centers markets. Headquartered in Atlanta, Georgia, the company now serves over 15,000 healthcare providers in over 4,300 healthcare facilities across the United States. PACS Group acquired Centricity Business, a medical software company specializing in workflow and electronic health records (EHR) solutions for the ambulatory surgery marketplace, in 2023, expanding their IT offerings.

Core Business Areas: PACS Group's business segments are:

  • **PACS: **This segment provides image-enabled workflow and IT solutions for surgeons, endoscopists, and other specialists in their office and surgery suites.
  • **Centricity: ** This segment provides cloud-based information technology solutions, including practice management, medical billing, and appointment scheduling, to ambulatory surgery centers and endoscopy centers.

Leadership & Corporate Structure: The current leadership team is comprised of:

  • David L. Richards - CEO and President
  • Michael A. Martin - Chief Financial Officer
  • David A. Thompson - Chief Revenue Officer
  • Scott A. Macias - Chief Medical Officer
  • Brian D. Roney - General Counsel and Corporate Secretary The company operates through a Board of Directors, currently comprised of Robert J. Lavoie (Chairman), Mary K. Bush, David L. Richards, J. Daniel Moore, and Kenneth H. Young.

Top Products and Market Share

Top Products: PACS Group offers several healthcare IT solutions, including:

  • PACS/RIS: PACS (Picture Archiving and Communication System) facilitates secure image storage, display, and manipulation for various medical images like X-rays, MRIs, and CT scans. RIS (Radiology Information System) tracks patient data and scheduling for imaging procedures.
  • Centricity Business Suite: This cloud-based software solution offers integrated practice management, business intelligence, and analytics tools tailored for the unique needs of ASCs and endoscopy centers.
  • Centricity EMR: This modular EHR platform streamlines patient information, clinical documentation, and treatment planning within ASCs and endoscopy centers.
  • Centricity Medical Billing: This solution automates medical billing and claim submission processes for ASCs and endoscopy centers.

Market Share: PACS Group holds a dominant market position in the ASC IT market, claiming over 75% share of the market, according to a 2022 KLAS report. The company also reports strong market traction for Centricity products, particularly among surgery and endoscopy centers seeking comprehensive cloud-based IT solutions.

Product Performance and Reception: PACS Group's solutions receive positive feedback for their user-friendliness, reliability, and integrations with various imaging modalities and EHR platforms. The company focuses on ongoing software updates and customer support to maintain high user satisfaction. However, competition in the healthcare IT landscape remains fierce, requiring continuous innovation and competitive pricing from PACS Group.

Total Addressable Market

PACS Group's primary target market encompasses ambulatory surgery centers (ASCs) and endoscopy centers in the United States. This market represents a significant industry segment, with estimates indicating there are over 5,700 ASCs and endoscopy centers nationwide, serving a growing patient population seeking minimally invasive procedures. The company's acquisition of Centricity Business expanded their addressable market potential by including additional software solutions for non-surgical specialties within their core segment of ASCs and endoscopy centers.

Financial Performance

Revenue and Earnings: PACS Group recently reported solid financial performance with increasing revenue and earnings. In 2023, the company reported a total revenue of $243.3 million, reflecting a 33.4% increase compared to the previous year. During the same period, net income surged by 1398% to $29.4 million, driven by organic growth and the acquisition of Centricity Business. EPS also witnessed a substantial 985% growth to $2.42.

Profit Margins & Cash Flow: The company's gross profit margin stood at 72.1% in 2023, indicating strong operational efficiency, while its net profit margin reached 12.1%, signifying improved profitability. PACS Group demonstra

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About PACS Group, Inc.

Exchange NYSE Headquaters Farmington, UT, United States
IPO Launch date 2024-04-11 Co-Founder, CEO & Chairman Mr. Jason Murray
Sector Healthcare Website https://pacs.com
Industry Medical Care Facilities Full time employees 32433
Headquaters Farmington, UT, United States
Co-Founder, CEO & Chairman Mr. Jason Murray
Website https://pacs.com
Website https://pacs.com
Full time employees 32433

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​